Beachbody (BODI) Q4 2025 Earnings Call Transcript

Beachbody reported Q4 revenue of $55.5M (down 35.7% YoY) driven by the exit from its MLM model, but delivered operating income of $8.2M (a $41.1M improvement YoY) and net income of $5.2M; adjusted EBITDA was $12.9M, up 48% YoY. Cash was $39M versus $25M of debt (net cash ~$15.4M), full-year free cash flow was $17.4M (vs -$2M prior year), and management gave Q1 2026 guidance of $49M–$54M revenue, adjusted EBITDA of $4M–$7M and net income of -$2M to $1M. Management outlined an omnichannel pivot with retail rollout (Shakeology seven-serve $34.99 into Sprouts in May), P90X supplement launches, and a new low-price Ten Minute Body tier, signaling a strategic shift toward higher-margin nutrition and broadened distribution.

Analysis

The company’s shift from a commission-heavy distributor model into an omnichannel mix is a structural margin lever — but the economic benefit only manifests if customer flows created by DTC performance marketing convert into durable retail velocity and repeat purchases. Expect early signals in multi-week to multi-quarter cadence: paid DTC campaigns that lower blended CAC for supplements, a measurable uplift in subscription attach-rates for buyers acquired via nutrition offers, and repeat reorder cadence from retail doors. If conversion from nutrition-first to subscription is > single-digit percentage points, blended LTV/CAC will re-rate materially; if not, the cost of retail inventory and promotions will compress unit economics faster than advertising efficiencies can offset.

Retail distribution materially changes working-capital and promotional dynamics. Partner-led placement (Advantage-type models) trades higher up-front selling friction for faster shelf presence, which usually brings slotting and promotional commitments that depress margins in early replenishment cycles. Operational levers to watch in the next 2–6 quarters are: shrink-to-fit planogram performance, retailer return rates/allowances, and incremental manufacturing scale benefits—each will determine whether gross-profit expansion from higher mix of nutrition is sustainable or a temporary spike.

The GLP-1 trend is a second-order demand accelerator if positioned as an adjunct: muscle-preserving training content plus high-protein/functional nutrition becomes a near-term upsell pathway into a fast-growing cohort. This is asymmetric positive optionality—low cost to build targeted content and offers, high potential wallet-share if the company captures even a small fraction of GLP-1 users. Key downside: if product positioning or clinical guidance misaligns, or if appetite suppression materially lowers repeat consumption, the thesis flips and retail inventory becomes a drag.

Execution is the gating factor. Binary catalysts over the next 3–12 months (retailer national push announcements, measurable cross-sell rates, and the first clean YoY quarter) will determine re-rating vs. reversion to legacy multiples. The right trading approach is time-boxed, catalyst-driven exposure with explicit hedges against promotional/slotting risk and inventory write-offs.

Key Decisions for Investors

• BODI — directional long via calendar call spread (9–12 month tenor): target a 2–3x payoff if the company prints clear retail purchase orders or posts clean YOY growth in Q3; cap max loss to premium paid. Rationale: asymmetric upside from retail scale + cross-sell; risk: execution/slotting/promotional cadence.
• BODI/ADV pair — long ADV (6–12 months) and long BODI exposure: ADV should realize earlier, steady revenue from placement fees and distribution. Trade size: modest (1–2% NAV) with stop-loss on ADV if no PO confirmations in 60 days. Rationale: ADV is a levered call on the retail rollout; downside: retail chains renegotiate terms or delay listings.
• Hedge for longs — buy short-dated puts on BODI or fund long exposure by selling near-term call premium (30–90 day): use these to protect against headline-driven negative prints (inventory write-offs, retailer returns) ahead of retail cadence. Timebox hedge through next two earnings/retail-announcement windows.
• SHOP — tactical long (3–6 months): small position to capture incremental DTC conversion benefit from Shopify migration; exit on a post-migration conversion-rate release or within 6 months. Rationale: migration risk is low-probability; reward is modest but relatively quick if conversion lifts.